BIO X CELL PROMOTIONFree Bio X Cell In Vivo Antibody Promotion for Mouse Model ResearchResearchers starting new mouse...
Drug Discovery Articles
IL-23: A Key Target for the Treatment of Immune-Mediated Inflammatory Diseases
ARTICLE FROM KACTUS IL-23: A Key Target for the Treatment of Immune-Mediated Inflammatory Diseases In KACTUS ’s recent...
Translational Continuity: Why Drug Programs Fail Early
ARTICLE BY BIO X CELLTranslational Continuity: Why Drug Programs Fail EarlyIn a recent blog post titled "Translational...
Mouse-Ready vs In Vivo-Ready Antibodies: Protecting Antibody Performance In Vivo
ARTICLE BY BIO X CELLFactors That Influence Antibody Performance In VivoBio X Cell has recently published an...
Emerging Therapeutic Strategies in Cancer Research
ARTICLE BY BIO X CELLEmerging Therapeutic Strategies in Cancer ResearchBio X Cell has recently published a...
Bio X Cell Introduces First Commercially Available Anti-Mouse Trispecific Antibody for Preclinical Research
ARTICLE BY BIO X CELLBio X Cell Introduces First Commercially Available Anti-Mouse Trispecific Antibody for...
The Reproducibility Crisis Is a Reagent Crisis
ARTICLE BY BIO X CELLThe Reproducibility Crisis Is a Reagent CrisisFor more than a decade, concerns regarding...
How Fc Engineering Improves Mechanistic Clarity in In Vivo Studies
ARTICLE BY BIO X CELLHow Fc Engineering Improves Mechanistic Clarity in In Vivo StudiesBio X Cell has recently...
Posters download: Tumor microenvironment (TME) posters from GeneTex
POSTERS ON TUMOR MICROENVIRONMENT (TME) POSTERS DOWNLOAD: THE TUMOR MICROENVIROMENT (TME) POSTERS FROM...
c-MET: A Key Target in Cancer Therapy Research
ARTICLE FROM KACTUS Article: c-MET: A Key Target in Cancer Therapy Research Laruen He from KACTUS has recently...
LIVE WEBINAR: Rethinking In Vivo Antibody Selection: A Masterclass in Functional Antibodies
WEBINAR BY BIO X CELLRethinking In Vivo Antibody Selection: A Masterclass in Functional AntibodiesMay 29th, 2026 |...
In vivo functional antibodies
ARTICLE BY BIO X CELLIn vivo functional antibodiesBio X Cell introduces a comprehensive portfolio of in vivo...
CDH17: The Next Breakthrough in Gastrointestinal Cancer Therapy by KACTUS
ARTICLE FROM KACTUS Article: CDH17: The Next Breakthrough in Gastrointestinal Cancer Therapy Natasha Slepak from...
About Multispecific Antibodies – Article by Bio X Cell
ARTICLE BY BIO X CELLAbout Multispecific AntibodiesBio X Cell has recently published a comprehensive guide titled...
From Oncology to Autoimmunity: The “Old” Target CD20 Still Holds Great Promise – Article from KACTUS
ARTICLE FROM KACTUS Article: From Oncology to Autoimmunity: The “Old” Target CD20 Still Holds Great Promise Natasha...